Skip to main content
British Journal of Clinical Pharmacology logoLink to British Journal of Clinical Pharmacology
. 1977 Apr;4(2):185–191. doi: 10.1111/j.1365-2125.1977.tb00692.x

Phenytoin concentrations in mixed, parotid and submandibular saliva and serum measured by radioimmunoassay.

J W Paxton, B Whiting, K W Stephen
PMCID: PMC1429005  PMID: 861132

Abstract

1 Concentrations of phenytoin in mixed, parotid and submandibular saliva and serum were determined in normal subjects after an oral dose, using a specific double antibody radioimmunoassay which requires only 20 micronl fluid. 2 Semi-log concentration-time plots of phenytoin concentration in mixed saliva and serum gave good parallelism after the initial 14 h post-administration period. 3 The mean ratio of the mixed saliva: serum phenytoin concentration was 10.3% +/- 1.5 (s.d.) in seven normal subjects. 4 Phenytoin concentrations found in separate parotid and submandibular salivary fractions did not differ but were significantly greater (P less than 0.001) than those found in mixed saliva. 5 Phenytoin concentrations in all salivary fractions were independent of the volume of fluid produced and the degree of stimulation. 6 The rate of phenytoin secretion in the parotid and submandibular fluid was proportional to the salivary flow rate. 7 These data suggest that mixed saliva may be a suitable medium for the monitoring of phenytoin concentrations and may provide a non-invasive alternative to the direct determination of phenytoin in serum.

Full text

PDF
185

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Cook C. E., Amerson E., Poole W. K., Lesser P., O'Tuama L. Phenytoin and phenobarbital concentrations in saliva and plasma measured by radioimmunoassay. Clin Pharmacol Ther. 1975 Dec;18(6):742–747. doi: 10.1002/cpt1975186742. [DOI] [PubMed] [Google Scholar]
  2. Paxton J. W., Rowell F. J., Ratcliffe J. G. Production and characterisation of antisera to diphenylhydantoin suitable for radioimmunoassay. J Immunol Methods. 1976;10(4):317–327. doi: 10.1016/0022-1759(76)90026-0. [DOI] [PubMed] [Google Scholar]
  3. Paxton J. W., Rowell F., Ratcliffe J. G., Lambie D. G., Nanda R., Melville I. D., Johnson R. H. Salivary phenytoin radioimmunoassay. A simple method of the assessment of non-protein bound drug concentrations. Eur J Clin Pharmacol. 1977;11(1):71–74. doi: 10.1007/BF00561791. [DOI] [PubMed] [Google Scholar]
  4. Reynolds F., Ziroyanis P. N., Jones N. F., Smith S. E. Salivary phenytoin concentrations in epilepsy and in chronic renal failure. Lancet. 1976 Aug 21;2(7982):384–386. doi: 10.1016/s0140-6736(76)92404-1. [DOI] [PubMed] [Google Scholar]
  5. SHANNON I. L. Parotid fluid flow rate as related to whole saliva volume. Arch Oral Biol. 1962 May-Jun;7:391–394. doi: 10.1016/0003-9969(62)90032-8. [DOI] [PubMed] [Google Scholar]
  6. Stephen K. W., Speirs C. F. Methods for collecting individual components of mixed saliva: the relevance to clinical pharmacology. Br J Clin Pharmacol. 1976 Apr;3(2):315–319. doi: 10.1111/j.1365-2125.1976.tb00609.x. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Journal of Clinical Pharmacology are provided here courtesy of British Pharmacological Society

RESOURCES